Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

NCT00560495 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: ammonium tetrathiomolybdate
OTHER: immunoenzyme technique
OTHER: laboratory biomarker analysis
RADIATION: Tc 99m sestamibi
RADIATION: radiation therapy

Sponsor

Roswell Park Cancer Institute